Thalidomide.
B R
BR
Allen
D003879:Dermatologic Agents / Q000627:therapeutic use; D006801:Humans; D006993:Hypnotics and Sedatives / Q000009:adverse effects*; D007917:Leprostatic Agents / Q000627:therapeutic use; D013723:Teratogens; D013792:Thalidomide / Q000009:adverse effects* / Q000627:therapeutic use
D003879:Dermatologic Agents; D006993:Hypnotics and Sedatives; D007917:Leprostatic Agents; D013723:Teratogens; D013792:Thalidomide